Cargando…

Management of Neonatal Diabetes due to a KCNJ11 Mutation with Automated Insulin Delivery System and Remote Patient Monitoring

Neonatal diabetes mellitus (NDM) is a monogenic form of diabetes. Management of hyperglycemia in neonates with subcutaneous insulin is challenging because of frequent feeding, variable quantity of milk intake with each feed, low insulin dose requirements, and high risk for hypoglycemia and associate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Ming Yeh, Gloyn, Anna L., Maahs, David M., Prahalad, Priya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468271/ https://www.ncbi.nlm.nih.gov/pubmed/37664823 http://dx.doi.org/10.1155/2023/8825724

Ejemplares similares

Transient Neonatal Diabetes due to a Mutation in KCNJ11 in a Child with Klinefelter Syndrome
por: Dahl, Amanda R., et al.
Publicado: (2018)

A Novel KCNJ11 Mutation Associated with Transient Neonatal Diabetes
por: Gole, Evangelia, et al.
Publicado: (2018)

A novel mutation KCNJ11 R136C caused KCNJ11-MODY
por: Chen, Yaning, et al.
Publicado: (2021)

SUN-278 Neonatal Diabetes in an Infant with Heterozygous Mutation in KCNJ11 Gene
por: Kota, Archana, et al.
Publicado: (2019)

Sulfonylurea Therapy in Two Korean Patients with Insulin-treated Neonatal Diabetes due to Heterozygous Mutations of the KCNJ11 Gene Encoding Kir6.2
por: Kim, Min Sun, et al.
Publicado: (2007)

Psychiatric morbidity in children with KCNJ11 neonatal diabetes
por: Bowman, P., et al.
Publicado: (2016)

Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes
por: Babiker, Tarig, et al.
Publicado: (2016)

First case of neonatal diabetes with KCNJ11 Q52R mutation successfully switched from insulin to sulphonylurea treatment
por: Ioacara, Sorin, et al.
Publicado: (2017)

Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutations
por: Kapoor, R. R., et al.
Publicado: (2011)

Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study
por: Bowman, Pamela, et al.
Publicado: (2018)

Case report: Neonatal diabetes mellitus caused by KCNJ11 mutation presenting with intracranial hemorrhage
por: Wu, Bo, et al.
Publicado: (2023)

Neonatal Diabetes: Two Cases with Isolated Pancreas Agenesis due to Homozygous PTF1A Enhancer Mutations and One with Developmental Delay, Epilepsy, and Neonatal Diabetes Syndrome due to KCNJ11 Mutation
por: Evliyaoğlu, Olcay, et al.
Publicado: (2018)

Changing the Treatment of Permanent Neonatal Diabetes Mellitus from Insulin to Glibenclamide in a 4-Month-Old Infant with KCNJ11 Activating Mutation
por: Ilkhanipoor, Homa, et al.
Publicado: (2013)

Successful transition from insulin to sulphonylurea in a child with neonatal diabetes mellitus diagnosed beyond six months of age due to C42R mutation in the KCNJ11 gene
por: Poon, Sarah Wing-yiu, et al.
Publicado: (2022)

Transient neonatal diabetes due to a missense mutation (E227K) in the gene encoding the ATP-sensitive potassium channel (KCNJ11)
por: Martins, Luísa, et al.
Publicado: (2015)

Successful Transition From Insulin to Sulfonylurea Therapy in a Patient With Monogenic Neonatal Diabetes Owing to a KCNJ11 P333L Mutation
por: Philla, Katherine Q., et al.
Publicado: (2013)

MON-121 Successful Transition from Insulin to Sulfonylurea for a 26 Year Old Female with Neonatal Diabetes Secondary to KCNJ11 Gene Mutation
por: Ali, Sulaiman, et al.
Publicado: (2019)

Successful transition from insulin to sulfonylurea, on second attempt, in a 24-year-old female with neonatal diabetes secondary to KCNJ11 gene mutation
por: Hajji, Sulaiman, et al.
Publicado: (2021)

Successful sulfonylurea treatment in a patient with permanent neonatal diabetes mellitus with a novel KCNJ11 mutation
por: Ahn, Sung Yeon, et al.
Publicado: (2015)

A Novel Homozygous Mutation in the KCNJ11 Gene of a Neonate with Congenital Hyperinsulinism and Successful Management with Sirolimus
por: Ünal, Sevim, et al.
Publicado: (2016)

Successful switching from insulin to sulfonylurea in a 3-month-old infant with diabetes due to p.G53D mutation in KCNJ11
por: Yoon, Jong Seo, et al.
Publicado: (2018)

Mutational analysis of KCNJ11 in Chinese elderly essential hypertensive patients
por: Li, Jia-Yue, et al.
Publicado: (2012)

DEND Syndrome with Heterozygous KCNJ11 Mutation Successfully Treated with Sulfonylurea
por: Cho, Ja Hyang, et al.
Publicado: (2017)

A quantitative model to ensure capacity sufficient for timely access to care in a remote patient monitoring program
por: Chang, Annie, et al.
Publicado: (2023)

Successful transfer from insulin to oral sulfonylurea in a 3-year-old girl with a mutation in the KCNJ11 gene
por: Al-Mahdi, Maria, et al.
Publicado: (2010)

Birth weight and diazoxide unresponsiveness strongly predict the likelihood of congenital hyperinsulinism due to a mutation in ABCC8 or KCNJ11
por: Hewat, Thomas I., et al.
Publicado: (2021)

Case report: coeliac disease as a cause of secondary failure of glibenclamide therapy in a patient with permanent neonatal diabetes due to KCNJ11/R201C mutation
por: Iafusco, Dario, et al.
Publicado: (2021)

Patterns of postmeal insulin secretion in individuals with sulfonylurea-treated KCNJ11 neonatal diabetes show predominance of non-K(ATP)-channel pathways
por: Bowman, Pamela, et al.
Publicado: (2019)

Visuomotor Performance in KCNJ11-Related Neonatal Diabetes Is Impaired in Children With DEND-Associated Mutations and May Be Improved by Early Treatment With Sulfonylureas
por: Shah, Reshma P., et al.
Publicado: (2012)

Permanent Neonatal Diabetes in a Patient with a KCNJ11/Q52R Mutation Accompanied by Intermittent Hypoglycemia and Liver Failure
por: Shaw, Natalie D., et al.
Publicado: (2009)

Neonatal diabetes caused by a homozygous KCNJ11 mutation demonstrates that tiny changes in ATP sensitivity markedly affect diabetes risk
por: Vedovato, Natascia, et al.
Publicado: (2016)

A model to design financially sustainable algorithm-enabled remote patient monitoring for pediatric type 1 diabetes care
por: Dupenloup, Paul, et al.
Publicado: (2022)

Overcoming Barriers to Diabetes Technology in Youth with Type 1 Diabetes and Public Insurance: Cases and Call to Action
por: Lee, Ming Yeh, et al.
Publicado: (2022)

KCNJ11: Genetic Polymorphisms and Risk of Diabetes Mellitus
por: Haghvirdizadeh, Polin, et al.
Publicado: (2015)

Incretin hormone responses to carbohydrate and protein/fat are preserved in adults with sulfonylurea‐treated KCNJ11 neonatal diabetes
por: Bowman, Pamela, et al.
Publicado: (2023)

Case report: Better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants
por: Mancioppi, Valentina, et al.
Publicado: (2023)

Successful Transition From Insulin to Sulfonylurea Therapy in a Patient With Monogenic Neonatal Diabetes Owing to a KCNJ11 P333L Mutation. Diabetes Care 2013;36:e201
por: Philla, Katherine Q., et al.
Publicado: (2014)

Gain-of-Function Mutations in the K(ATP) Channel (KCNJ11) Impair Coordinated Hand-Eye Tracking
por: McTaggart, James S., et al.
Publicado: (2013)

Coexistence of Mosaic Uniparental Isodisomy and a KCNJ11 Mutation Presenting as Diffuse Congenital Hyperinsulinism and Hemihypertrophy
por: Kocaay, Pınar, et al.
Publicado: (2016)

Sulfonylurea Use During Entire Pregnancy in Diabetes Because of KCNJ11 Mutation: A Report of Two Cases
por: Gaal, Zsolt, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_tfeg4kujb7egk2r04c5t9krqpk